209 related articles for article (PubMed ID: 27481009)
1. Circulating Tumor Cells in Breast Cancer Patients.
Hall C; Valad L; Lucci A
Crit Rev Oncog; 2016; 21(1-2):125-39. PubMed ID: 27481009
[TBL] [Abstract][Full Text] [Related]
2. Circulating tumor cells in breast cancer: applications in personalized medicine.
Lee JS; Magbanua MJM; Park JW
Breast Cancer Res Treat; 2016 Dec; 160(3):411-424. PubMed ID: 27761678
[TBL] [Abstract][Full Text] [Related]
3. Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization.
Riethdorf S; Pantel K
Pathobiology; 2008; 75(2):140-8. PubMed ID: 18544969
[TBL] [Abstract][Full Text] [Related]
4. Circulating Tumor Cells in Breast Cancer.
Liang DH; Hall C; Lucci A
Recent Results Cancer Res; 2020; 215():127-145. PubMed ID: 31605227
[TBL] [Abstract][Full Text] [Related]
5. Circulating tumor cells in breast cancer: detection systems, molecular characterization, and future challenges.
Lianidou ES; Markou A
Clin Chem; 2011 Sep; 57(9):1242-55. PubMed ID: 21784769
[TBL] [Abstract][Full Text] [Related]
6. Enumeration and molecular characterization of circulating tumor cells as an innovative tool for companion diagnostics in breast cancer.
Harigopal M; Kowalski D; Vosoughi A
Expert Rev Mol Diagn; 2020 Aug; 20(8):815-828. PubMed ID: 32546017
[TBL] [Abstract][Full Text] [Related]
7. Correlation of hormone receptor status between circulating tumor cells, primary tumor, and metastasis in breast cancer patients.
Kalinsky K; Mayer JA; Xu X; Pham T; Wong KL; Villarin E; Pircher TJ; Brown M; Maurer MA; Bischoff FZ
Clin Transl Oncol; 2015 Jul; 17(7):539-46. PubMed ID: 25613123
[TBL] [Abstract][Full Text] [Related]
8. Identification of genomic signatures in circulating tumor cells from breast cancer.
Kanwar N; Hu P; Bedard P; Clemons M; McCready D; Done SJ
Int J Cancer; 2015 Jul; 137(2):332-44. PubMed ID: 25529931
[TBL] [Abstract][Full Text] [Related]
9. Circulating tumor cells in patients with breast cancer: monitoring chemotherapy success.
Ušiaková Z; Mikulová V; Pintérová D; Brychta M; Valchář J; Kubecová M; Tesařová P; Bobek V; Kološtová K
In Vivo; 2014; 28(4):605-14. PubMed ID: 24982230
[TBL] [Abstract][Full Text] [Related]
10. Establishment of a multimarker qPCR panel for the molecular characterization of circulating tumor cells in blood samples of metastatic breast cancer patients during the course of palliative treatment.
Bredemeier M; Edimiris P; Tewes M; Mach P; Aktas B; Schellbach D; Wagner J; Kimmig R; Kasimir-Bauer S
Oncotarget; 2016 Jul; 7(27):41677-41690. PubMed ID: 27223437
[TBL] [Abstract][Full Text] [Related]
11. A novel method for downstream characterization of breast cancer circulating tumor cells following CellSearch isolation.
Frithiof H; Welinder C; Larsson AM; Rydén L; Aaltonen K
J Transl Med; 2015 Apr; 13():126. PubMed ID: 25896421
[TBL] [Abstract][Full Text] [Related]
12. Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients.
Königsberg R; Obermayr E; Bises G; Pfeiler G; Gneist M; Wrba F; de Santis M; Zeillinger R; Hudec M; Dittrich C
Acta Oncol; 2011 Jun; 50(5):700-10. PubMed ID: 21261508
[TBL] [Abstract][Full Text] [Related]
13. Clinical application of circulating tumor cells in breast cancer.
Broersen LH; van Pelt GW; Tollenaar RA; Mesker WE
Cell Oncol (Dordr); 2014 Feb; 37(1):9-15. PubMed ID: 24249155
[TBL] [Abstract][Full Text] [Related]
14. Review: circulating tumor cells in the practice of breast cancer oncology.
Ramos-Medina R; Moreno F; Lopez-Tarruella S; Del Monte-Millán M; Márquez-Rodas I; Durán E; Jerez Y; Garcia-Saenz JA; Ocaña I; Andrés S; Massarrah T; González-Rivera M; Martin M
Clin Transl Oncol; 2016 Aug; 18(8):749-59. PubMed ID: 26646763
[TBL] [Abstract][Full Text] [Related]
15. Circulating Tumor Cells.
Paoletti C; Hayes DF
Adv Exp Med Biol; 2016; 882():235-58. PubMed ID: 26987538
[TBL] [Abstract][Full Text] [Related]
16. Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis.
Giuliano M; Herrera S; Christiny P; Shaw C; Creighton CJ; Mitchell T; Bhat R; Zhang X; Mao S; Dobrolecki LE; Al-rawi A; Chen F; Veneziani BM; Zhang XH; Hilsenbeck SG; Contreras A; Gutierrez C; Jeselsohn RM; Rimawi MF; Osborne CK; Lewis MT; Schiff R; Trivedi MV
Breast Cancer Res; 2015 Jan; 17(1):3. PubMed ID: 25572662
[TBL] [Abstract][Full Text] [Related]
17. Cell-Free DNA and Circulating Tumor Cells: Comprehensive Liquid Biopsy Analysis in Advanced Breast Cancer.
Rossi G; Mu Z; Rademaker AW; Austin LK; Strickland KS; Costa RLB; Nagy RJ; Zagonel V; Taxter TJ; Behdad A; Wehbe FH; Platanias LC; Gradishar WJ; Cristofanilli M
Clin Cancer Res; 2018 Feb; 24(3):560-568. PubMed ID: 29180605
[No Abstract] [Full Text] [Related]
18. EpCAM based capture detects and recovers circulating tumor cells from all subtypes of breast cancer except claudin-low.
Ring A; Mineyev N; Zhu W; Park E; Lomas C; Punj V; Yu M; Barrak D; Forte V; Porras T; Tripathy D; Lang JE
Oncotarget; 2015 Dec; 6(42):44623-34. PubMed ID: 26556851
[TBL] [Abstract][Full Text] [Related]
19. Advances in the Characterization of Circulating Tumor Cells in Metastatic Breast Cancer: Single Cell Analyses and Interactions, and Patient-Derived Models for Drug Testing.
Kujur PK; Flores BCT; Ramalingam N; Chinen LTD; Jeffrey SS
Adv Exp Med Biol; 2020; 1220():61-80. PubMed ID: 32304080
[TBL] [Abstract][Full Text] [Related]
20. Clinical Relevance and Therapeutic Application of CTCs in Advanced Breast Cancer.
Cueva Bañuelos JF; Rodríguez López C; Cortegoso Mosquera A; Palacios Ozores P; Curiel García T
Adv Exp Med Biol; 2020; 1220():147-164. PubMed ID: 32304085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]